Seminars in Hematology
Volume 44, Supplement 3 , Pages S2-S6, April 2007

Evaluation of Iron Levels to Avoid the Clinical Sequelae of Iron Overload

  • Ali Taher

      Affiliations

    • Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
    • Corresponding Author InformationAddress correspondence to Professor Ali Taher, MD, Department of Internal Medicine, American University of Beirut, PO Box 11-0236, Beirut 1107 2020, Lebanon.
  • ,
  • David Nathan

      Affiliations

    • Dana-Farber Cancer Institute, Boston, MA.
  • ,
  • John Porter

      Affiliations

    • Department of Haematology, University College London, London, UK.

The success of transfusion therapy for the treatment of chronic anemia has resulted in the additional clinical challenge of managing iron overload and related morbidity and mortality issues. Effective chelation therapy can control iron levels, and regular assessment of body iron burden is crucial to guide initiation and ensure correct dosing of treatment. A range of techniques are now available that allow accurate assessment of iron burden through evaluation of serum ferritin levels, or the concentration of iron in key organs such as the liver and heart. Studies have enabled threshold values to be identified, above which the risk of serious clinical sequelae is increased.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0037-1963(07)00053-4

doi:10.1053/j.seminhematol.2007.03.002

Seminars in Hematology
Volume 44, Supplement 3 , Pages S2-S6, April 2007